Ikarian Capital, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$1,369,000
+139.8%
16,1000.0%0.10%
+120.0%
Q2 2020$571,000
-63.5%
16,100
-86.1%
0.04%
-61.9%
Q1 2020$1,565,000
-83.5%
116,100
-74.1%
0.12%
-92.3%
Q4 2019$9,484,000448,2001.54%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders